Sex-Specific Differences in Subclinical Organ Damage and Cardiovascular Risk Stratification Among Patients Classified

Lucyna Woźnicka-Leśkiewicz1, Anna Posadzy-Małaczyńska2

  • 1Department of Family Medicine, Poznan University of Medical Sciences, ul. Przybyszewskiego 49, 60-355, Poznań, Poland. lucyna.woznicka@gmail.com.

Insights

Cardiovascular risk assessment differs between sexes. This study found sex-specific correlations between biomarkers like ABI and PWV and cardiovascular risk scores, suggesting tailored approaches are needed.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Preventive Medicine

Background:

  • Cardiovascular diseases (CVDs) are a leading cause of mortality globally.
  • Women experience CVDs more frequently than men, necessitating sex-specific research.

Purpose of the Study:

  • To investigate sex-based relationships between subclinical organ damage markers (ABI, PWV, IMT) and cardiovascular risk (SCORE2/SCORE2-OP).
  • To stratify these relationships by coronary artery disease (CAD) and hypertension (HT) status.

Main Methods:

  • 200 patients were categorized into four groups based on CAD and HT presence/absence.
  • Measurements included ankle-brachial index (ABI), pulse wave velocity (PWV), intima-media thickness (IMT), and SCORE2/SCORE2-OP risk scores.
  • Statistical analyses were performed using StatSoft Statistica 10.

Main Results:

  • Men generally had higher cardiovascular risk scores than women across hypertensive and non-hypertensive groups.
  • In women without CAD, cardiovascular risk correlated with ABI and IMT.
  • In men without CAD and HT, cardiovascular risk correlated with PWV and IMT.
  • Logistic regression revealed sex-specific correlations: ABI with risk in women, PWV with risk in men within the primary prevention group.

Conclusions:

  • Significant sex-related differences exist in cardiovascular risk profiles and disease progression.
  • Sex-specific models may enhance cardiovascular risk assessment accuracy.
  • Findings underscore the importance of sex-specific approaches in CVD risk stratification and management.
Abstract

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
467
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
878
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
391
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
538
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
465
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
367